Josserand, V.; Bernard, C.; Michy, T.; Guidetti, M.; Vollaire, J.; Coll, J.-L.; Hurbin, A.
Tumor-Specific Imaging with Angiostamp800 or Bevacizumab-IRDye 800CW Improves Fluorescence-Guided Surgery over Indocyanine Green in Peritoneal Carcinomatosis. Biomedicines 2022, 10, 1059.
https://doi.org/10.3390/biomedicines10051059
AMA Style
Josserand V, Bernard C, Michy T, Guidetti M, Vollaire J, Coll J-L, Hurbin A.
Tumor-Specific Imaging with Angiostamp800 or Bevacizumab-IRDye 800CW Improves Fluorescence-Guided Surgery over Indocyanine Green in Peritoneal Carcinomatosis. Biomedicines. 2022; 10(5):1059.
https://doi.org/10.3390/biomedicines10051059
Chicago/Turabian Style
Josserand, Véronique, Claire Bernard, Thierry Michy, Mélanie Guidetti, Julien Vollaire, Jean-Luc Coll, and Amandine Hurbin.
2022. "Tumor-Specific Imaging with Angiostamp800 or Bevacizumab-IRDye 800CW Improves Fluorescence-Guided Surgery over Indocyanine Green in Peritoneal Carcinomatosis" Biomedicines 10, no. 5: 1059.
https://doi.org/10.3390/biomedicines10051059
APA Style
Josserand, V., Bernard, C., Michy, T., Guidetti, M., Vollaire, J., Coll, J. -L., & Hurbin, A.
(2022). Tumor-Specific Imaging with Angiostamp800 or Bevacizumab-IRDye 800CW Improves Fluorescence-Guided Surgery over Indocyanine Green in Peritoneal Carcinomatosis. Biomedicines, 10(5), 1059.
https://doi.org/10.3390/biomedicines10051059
